1887
Preview this article:
Zoom in
Zoomout

Carbapenems: do they have a future?, Page 1 of 1

| /docserver/preview/fulltext/jmm/60/9/1229_jmm031013-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.031013-0
2011-09-01
2021-02-25
Loading full text...

Full text loading...

/deliver/fulltext/jmm/60/9/1229.html?itemId=/content/journal/jmm/10.1099/jmm.0.031013-0&mimeType=html&fmt=ahah

References

  1. Amyes S. G. B., Walsh F. M., Bradley J. S. 2007; Best in class: a good principle for antibiotic usage to limit resistance development?. J Antimicrob Chemother 59:825–826 [CrossRef][PubMed]
    [Google Scholar]
  2. Brown S., Amyes S. G. B. 2006; OXA (β)-lactamases in Acinetobacter: the story so far. J Antimicrob Chemother 57:1–3 [CrossRef][PubMed]
    [Google Scholar]
  3. Doumith M., Ellington M. J., Livermore D. M., Woodford N. 2009; Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother 63:659–667 [CrossRef][PubMed]
    [Google Scholar]
  4. Edwards J. R. 1995; Meropenem: a microbiological overview. J Antimicrob Chemother 36:Suppl. A1–17[PubMed] [CrossRef]
    [Google Scholar]
  5. Gehrlein M., Leying H., Cullmann W., Wendt S., Opferkuch W. 1991; Imipenem resistance in Acinetobacter baumanii is due to altered penicillin-binding proteins. Chemotherapy 37:405–412 [CrossRef][PubMed]
    [Google Scholar]
  6. Girlich D., Poirel L., Nordmann P. 2009; CTX-M expression and selection of ertapenem resistance in Klebsiella pneumoniae and Escherichia coli . Antimicrob Agents Chemother 53:832–834 [CrossRef][PubMed]
    [Google Scholar]
  7. Jacoby G. A., Mills D. M., Chow N. 2004; Role of β-lactamases and porins in resistance to ertapenem and other β-lactams in Klebsiella pneumoniae . Antimicrob Agents Chemother 48:3203–3206 [CrossRef][PubMed]
    [Google Scholar]
  8. Kahan F. M., Kropp H., Sundelof J. G., Birnbaum J. 1983; Thienamycin: development of imipenen-cilastatin. J Antimicrob Chemother 12:Suppl. D1–35[PubMed] [CrossRef]
    [Google Scholar]
  9. Kumarasamy K. K., Toleman M. A., Walsh T. R., Bagaria J., Butt F., Balakrishnan R., Chaudhary U., Doumith M., Giske C. G. et al. 2010; Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10:597–602 [CrossRef][PubMed]
    [Google Scholar]
  10. Li J., Nation R. L., Turnidge J. D., Milne R. W., Coulthard K., Rayner C. R., Paterson D. L. 2006; Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis 6:589–601 [CrossRef][PubMed]
    [Google Scholar]
  11. Livermore D. M., Sefton A. M., Scott G. M. 2003; Properties and potential of ertapenem. J Antimicrob Chemother 52:331–344 [CrossRef][PubMed]
    [Google Scholar]
  12. Peleg A. Y., Seifert H., Paterson D. L. 2008; Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21:538–582 [CrossRef][PubMed]
    [Google Scholar]
  13. Poirel L., Nordmann P. 2002; Acquired carbapenem-hydrolyzing β-lactamases and their genetic support. Curr Pharm Biotechnol 3:117–127 [CrossRef][PubMed]
    [Google Scholar]
  14. Poirel L., Nordmann P. 2006; Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacillinase gene bla OXA-58 in Acinetobacter baumannii . Antimicrob Agents Chemother 50:1442–1448 [CrossRef][PubMed]
    [Google Scholar]
  15. Turton J. F., Ward M. E., Woodford N., Kaufmann M. E., Pike R., Livermore D. M., Pitt T. L. 2006; The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii . FEMS Microbiol Lett 258:72–77 [CrossRef][PubMed]
    [Google Scholar]
  16. Walsh T. R., Toleman M. A., Poirel L., Nordmann P. 2005; Metallo-β-lactamases: the quiet before the storm?. Clin Microbiol Rev 18:306–325 [CrossRef][PubMed]
    [Google Scholar]
  17. Wiseman L. R., Wagstaff A. J., Brogden R. N., Bryson H. M. 1995; Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs 50:73–101 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.031013-0
Loading

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error